SCM
GSK icon

Stevens Capital Management’s GSK GSK Stock Holding History

Stevens Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,230
Closed -$793K – 169
2020
Q4 		$793K Buy
17,230
+1,024
+6% +$47K 0.39% 49
2020
Q3 		$762K Buy
+16,206
New +$812K 0.28% 58
2020
Q1 		– Sell
-4,821
Closed -$283K – 181
2019
Q4 		$283K Buy
4,821
+249
+5% +$13.9K 0.03% 456
2019
Q3 		$244K Buy
+4,572
New +$235K 0.02% 487
2018
Q4 		– Sell
-32,295
Closed -$1.62M – 783
2018
Q3 		$1.62M Sell
32,295
-401
-1% -$20.4K 0.06% 339
2018
Q2 		$1.65M Buy
+32,696
New +$1.65M 0.06% 352
2017
Q4 		– Sell
-6,956
Closed -$353K – 907
2017
Q3 		$353K Sell
6,956
-25,583
-79% -$1.3M 0.01% 636
2017
Q2 		$1.75M Buy
32,539
+4,746
+17% +$253K 0.07% 331
2017
Q1 		$1.47M Sell
27,793
-13,385
-33% -$679K 0.06% 355
2016
Q4 		$1.98M Buy
41,178
+35,834
+671% +$1.77M 0.08% 316
2016
Q3 		$288K Buy
+5,344
New +$293K 0.01% 715
2015
Q2 		– Sell
-17,588
Closed -$1.01M – 1102
2015
Q1 		$1.01M Buy
17,588
+5,058
+40% +$290K 0.04% 415
2014
Q4 		$669K Sell
12,530
-12,057
-49% -$675K 0.02% 508
2014
Q3 		$1.41M Sell
24,587
-18,475
-43% -$1.13M 0.04% 385
2014
Q2 		$2.88M Buy
43,062
+15,816
+58% +$1.07M 0.08% 284
2014
Q1 		$1.82M Sell
27,246
-54,086
-67% -$3.66M 0.05% 370
2013
Q4 		$5.43M Buy
81,332
+46,876
+136% +$3.04M 0.16% 159
2013
Q3 		$2.16M Buy
+34,456
New +$2.22M 0.06% 326

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Stevens Capital Management's GSK Position: Q1 2021 in Review

Stevens Capital Management sold out of GSK (GSK) in Q1 2021, closing a stake of 17,230 shares — an estimated $793K sold.

Stevens Capital Management first reported a position in GSK in Q3 2013 and held it in 18 quarters. The position peaked at $5.43M in Q4 2013. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • Stevens Capital Management reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
  • Stevens Capital Management sold 17,230 GSK shares in Q1 2021, an estimated $793K.
  • Stevens Capital Management first reported a position in GSK in Q3 2013 and held it in 18 quarters.
  • Stevens Capital Management's GSK position peaked at $5.43M in Q4 2013.
  • 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Stevens Capital Management's 13F filing for Q1 2021, filed 11 May 2021.